202 related articles for article (PubMed ID: 32739274)
1. The Impact of Formulation Composition and Process Settings of Traditional Batch Versus Continuous Freeze-Drying On Protein Aggregation.
Vanbillemont B; Carpenter JF; Probst C; De Beer T
J Pharm Sci; 2020 Nov; 109(11):3308-3318. PubMed ID: 32739274
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of spin freezing versus conventional freezing as part of a continuous pharmaceutical freeze-drying concept for unit doses.
De Meyer L; Van Bockstal PJ; Corver J; Vervaet C; Remon JP; De Beer T
Int J Pharm; 2015 Dec; 496(1):75-85. PubMed ID: 25981618
[TBL] [Abstract][Full Text] [Related]
3. Instability of therapeutic proteins - An overview of stresses, stabilization mechanisms and analytical techniques involved in lyophilized proteins.
Butreddy A; Janga KY; Ajjarapu S; Sarabu S; Dudhipala N
Int J Biol Macromol; 2021 Jan; 167():309-325. PubMed ID: 33275971
[TBL] [Abstract][Full Text] [Related]
4. Applications of Freezing and Freeze-Drying in Pharmaceutical Formulations.
Izutsu KI
Adv Exp Med Biol; 2018; 1081():371-383. PubMed ID: 30288720
[TBL] [Abstract][Full Text] [Related]
5. Freeze-Drying of L-Arginine/Sucrose-Based Protein Formulations, Part 2: Optimization of Formulation Design and Freeze-Drying Process Conditions for an L-Arginine Chloride-Based Protein Formulation System.
Stärtzel P; Gieseler H; Gieseler M; Abdul-Fattah AM; Adler M; Mahler HC; Goldbach P
J Pharm Sci; 2015 Dec; 104(12):4241-4256. PubMed ID: 26422647
[TBL] [Abstract][Full Text] [Related]
6. Fundamentals of freeze-drying.
Nail SL; Jiang S; Chongprasert S; Knopp SA
Pharm Biotechnol; 2002; 14():281-360. PubMed ID: 12189727
[TBL] [Abstract][Full Text] [Related]
7. Impact of dextran on thermal properties, product quality attributes, and monoclonal antibody stability in freeze-dried formulations.
Haeuser C; Goldbach P; Huwyler J; Friess W; Allmendinger A
Eur J Pharm Biopharm; 2020 Feb; 147():45-56. PubMed ID: 31866444
[TBL] [Abstract][Full Text] [Related]
8. Stability of buffer-free freeze-dried formulations: A feasibility study of a monoclonal antibody at high protein concentrations.
Garidel P; Pevestorf B; Bahrenburg S
Eur J Pharm Biopharm; 2015 Nov; 97(Pt A):125-39. PubMed ID: 26455339
[TBL] [Abstract][Full Text] [Related]
9. Effects of buffer composition and processing conditions on aggregation of bovine IgG during freeze-drying.
Sarciaux JM; Mansour S; Hageman MJ; Nail SL
J Pharm Sci; 1999 Dec; 88(12):1354-61. PubMed ID: 10585234
[TBL] [Abstract][Full Text] [Related]
10. Freeze-drying: A flourishing strategy to fabricate stable pharmaceutical and biological products.
Abla KK; Mehanna MM
Int J Pharm; 2022 Nov; 628():122233. PubMed ID: 36183914
[TBL] [Abstract][Full Text] [Related]
11. Impact of critical process and formulation parameters affecting in-process stability of lactate dehydrogenase during the secondary drying stage of lyophilization: a mini freeze dryer study.
Luthra S; Obert JP; Kalonia DS; Pikal MJ
J Pharm Sci; 2007 Sep; 96(9):2242-50. PubMed ID: 17621675
[TBL] [Abstract][Full Text] [Related]
12. Rapid optimization of protein freeze-drying formulations using ultra scale-down and factorial design of experiment in microplates.
Grant Y; Matejtschuk P; Dalby PA
Biotechnol Bioeng; 2009 Dec; 104(5):957-64. PubMed ID: 19530082
[TBL] [Abstract][Full Text] [Related]
13. Formulation Screening and Freeze-Drying Process Optimization of Ginkgolide B Lyophilized Powder for Injection.
Liu D; Galvanin F; Yu Y
AAPS PharmSciTech; 2018 Feb; 19(2):541-550. PubMed ID: 28849380
[TBL] [Abstract][Full Text] [Related]
14. Crystallizing amino acids as bulking agents in freeze-drying.
Horn J; Tolardo E; Fissore D; Friess W
Eur J Pharm Biopharm; 2018 Nov; 132():70-82. PubMed ID: 30201570
[TBL] [Abstract][Full Text] [Related]
15. The impact of drying method and formulation on the physical properties and stability of methionyl human growth hormone in the amorphous solid state.
Abdul-Fattah AM; Lechuga-Ballesteros D; Kalonia DS; Pikal MJ
J Pharm Sci; 2008 Jan; 97(1):163-84. PubMed ID: 17722086
[TBL] [Abstract][Full Text] [Related]
16. Impact of fast and conservative freeze-drying on product quality of protein-mannitol-sucrose-glycerol lyophilizates.
Horn J; Schanda J; Friess W
Eur J Pharm Biopharm; 2018 Jun; 127():342-354. PubMed ID: 29522899
[TBL] [Abstract][Full Text] [Related]
17. In-vial printing and drying of biologics as a personalizable approach.
Fiedler D; Alva C; Pinto JT; Spoerk M; Jeitler R; Roblegg E
Int J Pharm; 2022 Jul; 623():121909. PubMed ID: 35697202
[TBL] [Abstract][Full Text] [Related]
18. Freeze drying of human serum albumin (HSA) nanoparticles with different excipients.
Anhorn MG; Mahler HC; Langer K
Int J Pharm; 2008 Nov; 363(1-2):162-9. PubMed ID: 18672043
[TBL] [Abstract][Full Text] [Related]
19. Noncontact Infrared-Mediated Heat Transfer During Continuous Freeze-Drying of Unit Doses.
Van Bockstal PJ; De Meyer L; Corver J; Vervaet C; De Beer T
J Pharm Sci; 2017 Jan; 106(1):71-82. PubMed ID: 27321237
[TBL] [Abstract][Full Text] [Related]
20. Systematic investigation of the effect of lyophilizate collapse on pharmaceutically relevant proteins I: stability after freeze-drying.
Schersch K; Betz O; Garidel P; Muehlau S; Bassarab S; Winter G
J Pharm Sci; 2010 May; 99(5):2256-78. PubMed ID: 20039389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
